Prothena Corporation PLC PRTA.OQ PRTA.O is expected to show a fall in quarterly revenue when it reports results on November 12 for the period ending September 30 2024
The Dublin Ireland; Republic of-based company is expected to report a 98.6% decrease in revenue to $1.226 million from $84.87 million a year ago, according to the mean estimate from 8 analysts, based on LSEG data.
LSEG's mean analyst estimate for Prothena Corporation PLC is for a loss of $1.18 per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy," 2 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months.
Wall Street's median 12-month price target for Prothena Corporation PLC is $62.00, above its last closing price of $17.49.
Previous quarterly performance (using preferred earnings measure in US dollars).
QUARTER ENDING | STARMINESMARTESTIMATE® | LSEG IBES ESTIMATE | ACTUAL | BEAT, MET, MISSED | SURPRISE % |
Jun. 30 2024 | -1.02 | -1.05 | 1.22 | Beat | 215.8 |
Jan. 1 2024 | -1.20 | -1.20 | -1.34 | Missed | -11.6 |
Dec. 31 2023 | -1.24 | -1.22 | -1.26 | Missed | -3.6 |
Sep. 30 2023 | -0.35 | -0.32 | 0.38 | Beat | 218 |
Jun. 30 2023 | -1.10 | -1.00 | -1.03 | Missed | -3.4 |
Mar. 31 2023 | -0.98 | -0.94 | -0.89 | Beat | 5.8 |
Dec. 31 2022 | -0.42 | -0.47 | 0.12 | Beat | 125.8 |
Sep. 30 2022 | -0.53 | -0.53 | -0.97 | Missed | -83.5 |
This summary was machine generated November 8 at 21:41 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)